Paul Van Damme, MBA, CA
Chief Financial Officer
Mr. Van Damme has served in senior financial roles for a number of public companies in both the United States and Canada. He held a number of increasingly responsible positions while at Canada Systems Group from 1983 to 1991, culminating in his appointment as Chief Financial Officer in 1988. In 1991, Paul joined Laidlaw Inc. and helped implement their expansion into Europe. After three years as Chief Financial Officer of TeleZone Inc., a start-up wireless telecommunications company, he joined a private biotech company and helped raise venture financing to expand their product portfolio. Mr. Van Damme later joined Allelix Pharmaceuticals Inc. and participated in the sale of the company to NPS Pharmaceuticals, Inc. of Salt Lake City. Most recently, he was the CFO for Bradmer Pharmaceuticals Inc.
Paul received his undergraduate degree (B.Comm.) from the University of Toronto and his M.B.A. from the Rotman School of Management. He is a Chartered Professional Accountant and articled with PricewaterhouseCoopers where he served as Audit Manager in London, England and Toronto, Canada. He currently serves as a director of Quest PharmaTech Inc.